A carregar...

Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update

Ten mammalian diacylglycerol kinase (DGK) isozymes (α–κ) have been identified to date. Our previous review noted that several DGK isozymes can serve as potential drug targets for cancer, epilepsy, autoimmunity, cardiac hypertrophy, hypertension and type II diabetes (Sakane et al., 2008). Since then,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Dev Biol
Main Authors: Sakane, Fumio, Mizuno, Satoru, Komenoi, Suguru
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4987324/
https://ncbi.nlm.nih.gov/pubmed/27583247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2016.00082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!